These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 32630787)

  • 1. Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters.
    Woźnicki P; Westhoff N; Huber T; Riffel P; Froelich MF; Gresser E; von Hardenberg J; Mühlberg A; Michel MS; Schoenberg SO; Nörenberg D
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
    Hectors SJ; Chen C; Chen J; Wang J; Gordon S; Yu M; Al Hussein Al Awamlh B; Sabuncu MR; Margolis DJA; Hu JC
    J Magn Reson Imaging; 2021 Nov; 54(5):1466-1473. PubMed ID: 33970516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance variability of radiomics machine learning models for the detection of clinically significant prostate cancer in heterogeneous MRI datasets.
    Gresser E; Schachtner B; Stüber AT; Solyanik O; Schreier A; Huber T; Froelich MF; Magistro G; Kretschmer A; Stief C; Ricke J; Ingrisch M; Nörenberg D
    Quant Imaging Med Surg; 2022 Nov; 12(11):4990-5003. PubMed ID: 36330197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of machine learning models based on biparametric MRI for diagnosis of prostate cancer and clinically significant prostate cancer].
    Qiao XM; Hu CH; Hu S; Hu CH; Wang XM; Shen JK; Ji LB; Song Y; Bao J
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1446-1454. PubMed ID: 37198106
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging radiomics-based prediction of clinically significant prostate cancer in equivocal PI-RADS 3 lesions in the transitional zone.
    Zhao YY; Xiong ML; Liu YF; Duan LJ; Chen JL; Xing Z; Lin YS; Chen TH
    Front Oncol; 2023; 13():1247682. PubMed ID: 38074651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-based radiomics model to predict benign and malignant PI-RADS v2.1 category 3 lesions: a retrospective multi-center study.
    Jin P; Shen J; Yang L; Zhang J; Shen A; Bao J; Wang X
    BMC Med Imaging; 2023 Mar; 23(1):47. PubMed ID: 36991347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4∼10ng/mL: Biparametric versus multiparametric MRI.
    Han C; Liu S; Qin XB; Ma S; Zhu LN; Wang XY
    Diagn Interv Imaging; 2020 Apr; 101(4):235-244. PubMed ID: 32063483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and diffusion features for identification of clinically significant prostate cancer in PI-RADS 3 lesions.
    Ajami T; Han S; Porto JG; Kimbel I; Szczotka Z; Guerard T; VanderVeer-Harris N; Ledesma BR; Acosta PC; Kryvenko ON; Parekh DJ; Stoyanova R; Reis IM; Punnen S
    Urol Oncol; 2024 Nov; 42(11):370.e9-370.e14. PubMed ID: 38971674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score.
    Pellegrino F; Stabile A; Sorce G; Quarta L; Robesti D; Cannoletta D; Cirulli G; Barletta F; Scuderi S; Mazzone E; de Angelis M; Brembilla G; De Cobelli F; Salonia A; Montorsi F; Briganti A; Gandaglia G
    Eur Urol Focus; 2024 Jul; 10(4):634-640. PubMed ID: 37865591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions.
    Brancato V; Aiello M; Basso L; Monti S; Palumbo L; Di Costanzo G; Salvatore M; Ragozzino A; Cavaliere C
    Sci Rep; 2021 Jan; 11(1):643. PubMed ID: 33436929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning model for the detection of prostate cancer and classification of clinically significant disease using multiparametric MRI in comparison to PI-RADs score.
    Yang C; Li B; Luan Y; Wang S; Bian Y; Zhang J; Wang Z; Liu B; Chen X; Hacker M; Li Z; Li X; Wang Z
    Urol Oncol; 2024 May; 42(5):158.e17-158.e27. PubMed ID: 38388243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics Models Based on Apparent Diffusion Coefficient Maps for the Prediction of High-Grade Prostate Cancer at Radical Prostatectomy: Comparison With Preoperative Biopsy.
    Han C; Ma S; Liu X; Liu Y; Li C; Zhang Y; Zhang X; Wang X
    J Magn Reson Imaging; 2021 Dec; 54(6):1892-1901. PubMed ID: 33682286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Texture analysis based on PI-RADS 4/5-scored magnetic resonance images combined with machine learning to distinguish benign lesions from prostate cancer.
    Ma L; Zhou Q; Yin H; Ang X; Li Y; Xie G; Li G
    Transl Cancer Res; 2022 May; 11(5):1146-1161. PubMed ID: 35706813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics from multisite MRI and clinical data to predict clinically significant prostate cancer.
    Krauss W; Frey J; Heydorn Lagerlöf J; Lidén M; Thunberg P
    Acta Radiol; 2024 Mar; 65(3):307-317. PubMed ID: 38115809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis.
    Lim CS; Abreu-Gomez J; Thornhill R; James N; Al Kindi A; Lim AS; Schieda N
    Abdom Radiol (NY); 2021 Dec; 46(12):5647-5658. PubMed ID: 34467426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions.
    Li T; Sun L; Li Q; Luo X; Luo M; Xie H; Wang P
    Front Oncol; 2021; 11():825429. PubMed ID: 35155214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer.
    Tavakoli AA; Hielscher T; Badura P; Görtz M; Kuder TA; Gnirs R; Schwab C; Hohenfellner M; Schlemmer HP; Bonekamp D
    Radiology; 2023 Jan; 306(1):186-199. PubMed ID: 35972360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a nomogram combining multiparametric magnetic resonance imaging and PSA-related parameters to enhance the detection of clinically significant cancer across different region.
    Zhou Z; Liang Z; Zuo Y; Zhou Y; Yan W; Wu X; Ji Z; Li H; Hu M; Ma L
    Prostate; 2022 Apr; 82(5):556-565. PubMed ID: 35098557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
    Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.